Patient
SITE012-0006
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2025-08-29
Adverse events
6
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-05 (study day 154); relationship: not assessed
Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-07-14 (study day 132); relationship: NOT RELATED
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-05-15 (study day 72); relationship: not assessed
Grade 3 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2022-04-12 (study day 39); relationship: not assessed; serious criteria: hospitalization
Grade 1 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2022-04-07 (study day 34); relationship: not assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-03-17 (study day 13); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.